WNT5A and neoplasm: During ErbB2-induced mammary tumorigenesis, basal tumor-initiating cells (TIC), which exhibited enhanced tumorigenic capacity compared with the corresponding luminal progenitors, preferentially lost Wnt5a expression, as determined by transcript profiling analysis.